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ABSTRACT
L-cysteine is currently recognized as a conditionally essential sulphur amino acid. Besides contributing to many biological pathways, cysteine
is a key component of the keratin protein by its ability to form disulﬁde bridges that confer strength and rigidity to the protein. In addition to
cysteine, iron represents another critical factor in regulating keratins expression in epidermal tissues, as well as in hair follicle growth and
maturation. By focusing on human keratinocytes, the aim of this study was to evaluate the effect of cysteine supplementation as nutraceutical
on keratin biosynthesis, as well as to get an insight on the interplay of cysteine availability and cellular iron status in regulating keratins
expression in vitro. Herein we demonstrate that cysteine promotes a signiﬁcant up-regulation of keratins expression as a result of de novo
protein synthesis, while the lack of iron impairs keratin expression. Interestingly, cysteine supplementation counteracts the adverse effect of
iron deﬁciency on cellular keratin expression. This effect was likelymediated by the up-regulation of transferrin receptor and ferritin, themain
cellular proteins involved in iron homeostasis, at last affecting the labile iron pool. In this manner, cysteine may also enhance the metabolic
iron availability for DNA synthesis without creating a detrimental condition of iron overload. To the best of our knowledge, this is one of the
ﬁrst study in an in vitro keratinocyte model providing evidence that cysteine and iron cooperate for keratins expression, indicative of their
central role in maintaining healthy epithelia. J. Cell. Biochem. 117: 402–412, 2016. © 2015 Wiley Periodicals, Inc.
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Keratins are members of the intermediate ﬁlament familypreferentially expressed in epithelial tissues. They are
responsible of the mechanical integrity of the epithelia at both
cellular and tissue level by forming a dense and stable network
spanning from the cell periphery to the nucleus of keratinocytes. In
addition to protecting epithelial cells frommechanical stress, keratins
participate in the regulation of cell growth, proliferation, migration
and apoptosis [Coulombe and Omary, 2002; Oshima, 2007; Vaidya
and Kanojia, 2007; Kim and Coulombe, 2007].More than 50 different
intermediate ﬁlament proteins have been identiﬁed and classiﬁed
into six groups based on their amino acid sequence. Epithelial cells
express two speciﬁc groups of keratins, type I acidic (e.i. K9–K28
and K31–K40) and type II basic (e.i. K1–K8 and K71–K86) which
copolymerize to form intermediate ﬁlaments (IF) [Schweizer et al.,
2006; Moll et al., 2008; Lee and Coulombe, 2009; Bragulla and
Homberger, 2009].Hair andnails express specialized type I and type II
keratin proteins which are extremely rich in cysteine, allowing an
high degree of cross-linking between the keratins and keratin-
associated proteins (KAPs) [Jones et al., 1997; Steinert, 2001]. The
importance of cysteine and its oxidized form, cystine, inmaintenance
of the healthy structure of hair has been demonstrated in several
studies in both humans and mice. Low levels of cysteine in hair have
been found in patients affected by trichothiodystrophy, a genetic
disorder characterized by hair fragility [Liang et al., 2006; Khumalo
et al., 2010]. On the other hand, oral administration of L-cysteine
combined with retinol has beneﬁc effects on hair loss in humans
[Hertel et al., 1989]. Moreover, L-cystine and vitamin B6 have been
shown in vivo to inhibit the smoke-induced alopecia in a dose
dependent manner [D0Agostini et al., 2007]. According to an early
study carried out on sheep on low quality diet, cysteine infusion
determined an increase of both keratin-associated proteins (KAP4)
mRNA and hair keratinocytes expressing the cysteine-rich KAP4
protein, without interfering with mRNA and protein levels of KAPs
with lower cysteine content [Fratini et al., 1994].
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Aswell as cysteine, iron represents another critical factor involved in
many physiological processes of hair follicle, such as growth,
maturation, and cell division, suggesting that iron deﬁciency
could affect hair synthesis [Trost et al., 2006; Elston, 2010; St Pierre
et al., 2010]. Indeed, several iron metabolism disorders, including
the ones characterized by dietary reduced adsorption, are associated
to anemia and hair loss, both resolved by iron supplementation
therapy [Du et al., 2008]. However, to date studies concerning
iron deﬁciency as a cause of hair loss have produced conﬂicting
results. The importance of adequate amounts of iron for health
is well known. This metal is essential for living cells as iron-
containing proteins play a central role in oxygen transport, electron
transport, and redox reactions. Moreover, the iron-dependent
enzyme ribonucleotide reductase is critical for DNA synthesis,
particularly in rapid turnover tissues—like epithelia—endowed with
high proliferative cells [Yu et al., 2007]. Biological accessible iron
in the cytoplasm is mainly divalent and potentially interacting
with local counter-ions, mostly thiol-containing compounds like
glutathione and cysteine itself. This pool—the “labile iron pool”
(LIP)—is now accepted to be at the crossroad between cellular iron
import and export, storage in ferritin and incorporation into
proteins. The LIP is potentially harmful because of its ability
to catalyze the formation of reactive oxygen species (ROS).
Consequently, though iron deﬁciency is detrimental to cells, iron
excess is equally toxic since ROS can damage several biomolecules
and cellular structures (Papanikolaou and Pantopoulos, 2005; Meli
et al., 2013). Therefore, to prevent the damaging consequences of
both iron deﬁciency and iron overload, intracellular iron level must
be maintained within a deﬁnite range. At cellular level, iron
homeostasis is achieved by the coordinated expression of proteins
involved in iron uptake, such as transferrin receptor 1 (TfR-1),
storage, such as ferritin, and export, such as ferroportin [Santamaria
et al., 2004; Hentze et al., 2010]. The expression of these proteins is
mainly regulated at post-transcriptional level by the binding of Iron
Regulatory Proteins (IRP1 and IRP2) to Iron Responsive Elements
(IRE), located in the 50untranslated region of ferritin and ferroportin
mRNAs and in the 30untranslated region of TfR1 mRNA. At systemic
level, iron homeostasis is regulated by hepcidin, a liver-produced
peptide hormone that promotes the degradation of the ferroportin in
speciﬁc cell types, thus reducing iron inﬂux in the extracellular
space [Ganz and Nemeth, 2012].
Taking into consideration the critical role played by cysteine and
iron in the maintenance of the biological functions of epithelial
cells, the aim of this study was to evaluate the biological effects of
cysteine on keratin biosynthesis, as well as to get an insight on the
interplay of cysteine availability and iron status in regulating
cellular keratins expression. For this reason we focused on the
possible impact of cysteine administration, coupled or not to iron-
overload/iron-deﬁciency, in keratins biosynthesis in vitro in human
HaCaT keratinocytes. These cells are a commonly used model system
for human epidermal keratinocytes since they retain an high
differentiation capacity and functional properties besides expressing
a wide spectrum of keratins [Breitkreutz et al., 1998]. Herein we show
that cellular keratins content was signiﬁcantly down-regulated by
iron deﬁcit and up-regulated by cysteine. Interestingly, cysteine
treatment was able to revert the negative effect of iron deﬁciency on
keratin synthesis, possibly via a regulation of the main proteins
involved in iron homeostasis thereby affecting LIPmagnitude. To the
best of our knowledge, this is one of the ﬁrst investigations showing
the coupled effects of cysteine and iron on keratins biosynthesis in
human keratinocytes.
MATERIALS AND METHODS
CELL CULTURES AND TREATMENTS
HaCaT cells, an immortalized, non-tumorigenic human keratinocyte
cell line, were cultured in Dulbecco0s modiﬁed Eagle0s medium
(DMEM, Invitrogen, Paisley, UK) containing high glucose (4.5 g/L),
supplemented with 10% fetal bovine serum (FBS, Cambrex, Verviers,
Belgium), L-glutamine (2mM, Sigma, Milan, Italy), penicillin
(100 units/ml, Sigma) and streptomycin (100mg/ml, Sigma) at
37°C in a humidiﬁed 5% CO2 atmosphere. At conﬂuence, the
complete culture medium was replaced with fresh complete medium
and cells were treated with various concentrations of L-cysteine
(Sigma) dissolved in sterile water for different time periods.
Similarly, control cells were subjected to replacement with fresh
complete medium.
For iron repletion/depletion experiments, cells were treated with
50mg/ml ferric ammonium citrate (FAC) (Sigma) or with 100mM
desferrioxamine (DFO) (Desferal, Novartis, Origgio, Varese, Italy) in
growth medium for 18 h.
ASSESSMENT OF CELL VIABILITY
HaCaT cells were seeded in 96-well plates at a density of 104 cells/
well. After 24 h the medium was replaced with fresh medium and
then the cells were treated for 24, 48, and 72 h with L-cysteine
at different concentrations (from 1nM to 100mM). Celll viability
was estimated with MTT assay, which measures the level of
mitochondrial dehydrogenase activity using 3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) as substrate
[Fiorito et al., 2013]. This assay is based on the redox ability of living
mitochondria to convert the tetrazolium salt, MTT, into insoluble
formazan. After treatments, the medium was removed and the
cells were incubated with 20ml/well of an MTT solution (5mg/ml)
for 1 h in a humidiﬁed 5% CO2 incubator at 37°C. The incubation
was stopped by removing the MTT solution and adding DMSO
(100ml/well) to solubilize the formazan. The absorbance was
monitored at 550 nm by using a microplate reader (iMark microplate
reader, Biorad, Milan, Italy). Data are expressed as mean percentage
of the viable cells versus the respective control.
Moreover, we evaluated the relative number of live and dead
cells using a MultiTox-Fluor Multiplex Cytotoxicity Assay (Promega,
Madison, WI). Brieﬂy, cells were plated into 96-well plates
(5 103/well) and after the treatment with cysteine, the solution
containing the ﬂuorogenic substrates for live-cell and dead-cell
protease activities was added to the cells. Following 30min at 37°C
the ﬂuorescence was measured in a Perkin Elmer microplate reader
(Perkin Elmer LS 55 Luminescence Spectrometer, Beaconsﬁeld, UK)
using a ﬁlter combination with an excitation wavelength of 400/
485nm and an emission wavelength of 505/520nm (slits 5 nm). Data
are expressed as percentage of viable cell versus control cultures.
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PREPARATION OF CELLULAR EXTRACTS
HaCaT cells were grown in the presence or absence of L-cysteine at
different concentrations (from 1 to 100mM). After treatment, protein
extracts were prepared according to previously described procedure
[Achtstaetter et al., 1986]. Brieﬂy, cell pellets were lysed at 4°C for
10min with buffer containing 1% Triton X-100, 5mM EDTA, in PBS
(pH 7.4) containing protease inhibitors. After centrifugation at
14,000g for 10min at 4°C, the supernatant was collected as the
soluble fraction and stored at80°C. The pellet was homogenized at
4°C for 30min in 1ml of 10mM Tris-HCl, pH 7.6, 140mM NaCl,
1.5M KCl, 5mM EDTA, 0.5% Triton X-100, and protease inhibitors.
After centrifugation at 14,000g for 10min at 4°C, the resulting pellet
(insoluble fraction) was resuspended in buffer containing 5mM
EDTA in PBS (pH 7.4) and stored at 80°C. To obtain cytosolic
extracts for Western blot analysis of iron related proteins (TfR-1,
ferritin and IRP1) cell pellets were lysed at 4°C for 30min in a buffer
containing 20mM Tris-HCl, pH 7.4, 150mM NaCl, 5mM EDTA, 5%
(v/v) glycerol, 10mM NP-40 and protease inhibitor tablets (Roche).
The supernatant fraction was obtained by centrifugation at 15,000g
for 10min at 4°C and then stored at 80°C.
Protein concentration was determined by the Bio-Rad protein
assay (Bio-Rad, Milan, Italy).
WESTERN BLOT ANALYSIS
The same amounts (50mg) of proteins from soluble and insoluble
fractions were loaded on 10% SDS–PAGE and electrotransferred
onto a nitrocellulose membrane (GE Healthcare, UK) using a Bio-Rad
Transblot (Bio-Rad). Proteins were visualized by reversible staining
with Ponceau-S solution and destained in PBS. Membranes were
blocked at room temperature in milk buffer [1PBS, 5–10% (w/v)
non-fat dry milk, 0.2% (v/v) Tween-20] and then incubated at 4°C
overnight with 1:250 monoclonal anti-Pan cytokeratin antibodies
(mixture) (Sigma–Aldrich, Milan, Italy) which recognize the
following human cytokeratins, according to their molecular weight:
K1 (68 kDa), K4 (59 kDa), K5 (58 kDa), K6/K10 (56 kDa), K13 (54 kDa),
K8 (52 kDa), K18 (45 kDa), and K19 (40 kDa). As a secondary
antibody was used a goat anti-mouse IgGþ IgM (1:5,000, Jackson
ImmunoResearch Laboratories, Baltimore Pike, West Grove, PA). For
Western blot analysis of TfR-1, ferritin and IRP1, samples containing
50mg of proteins were loaded on 12% (for ferritin) or 8% (for
IRP1 and TfR-1) SDS–PAGE and transferred to nitrocellulose
membranes. After blocking at room temperature in milk buffer
[1PBS, 5–10% (w/v) non-fat dry milk, 0.2% (v/v) Tween-20], the
membranes were incubated at 4°C overnight with 1:1,000 rabbit
polyclonal antibody to human ferritin (Dako Cytomation, Glostrup,
Denmark), or with 1:1,000 mouse monoclonal antibody to human
transferrin receptor 1 (Zymed Laboratories Inc., CA), or with 1:250
goat polyclonal antibody to human IRP1 (Santa Cruz Biotechnology,
Santa Cruz, CA), or with 1:250 goat polyclonal antibody to human
IRP2 (Santa Cruz Biotechnology). Subsequently, the membranes
were incubated with peroxidase-conjugated goat anti-rabbit IgG, or
peroxidase-conjugated goat antimouse IgGþIgM, or peroxidase-
conjugated rabbit anti-goat IgG (all the secondary antibodies
were purchased from Jackson ImmunoResearch Laboratories). The
immunocomplexes were visualized by the ECL chemoluminescence
method (ECL, Amersham Biosciences) and analyzed by an imaging
system (ImageQuantTM 400, GE Healthcare Life Sciences). Densito-
metric analyses were conducted using the GS-800 imaging
densitometer (Bio-Rad). b-actin antibody (Sigma–Aldrich) was
used to normalize the results.
METABOLIC LABELING WITH [35S]-METHIONINE AND
IMMUNOPRECIPITATION
Keratins biosynthesis was evaluated by immunoprecipitation after
[35S]-methionine metabolic labeling. In detail, HaCaT cells were
treated with L-cysteine 10mM for 48 h. During the ﬁnal 4 h of
treatment, cells were incubated ﬁrst in a methionine-free medium
(for 1 h) and then in methionine-free medium supplemented with
100mCi/ml L-[35S]-methionine (Perkin Elmer, Italy) for 3 h, as
previously described [Miniaci et al., 2013, 2015]. Cells were washed
three times with PBS and lysed to obtain the soluble and insoluble
fractions. Aliquots (300mg) of both fractions were incubated at 4°C
for 16 h with 5mg of anti-Pan cytokeratin antibody, previously
conjugated with protein G PLUS-Agarose (Santa Cruz Biotechnol-
ogy). After immunoprecipitation, the samples were washed three
times with the appropriate lysis buffer and boiled with SDS loading
buffer. Immunoprecipitated proteins were resolved using 10% SDS–
polyacrylamide gel. After electrophoresis, the gel was treated with
Amplify (Amersham Biosciences, UK) for 30min, ﬁxed in 50%
methanol and 10% acetic acid, dried, and then exposed at –80°C for
autoradiography. The intensity of the bands was quantiﬁed by
densitometric analysis and the incorporation of [35S]-methionine
into total proteins was normalized according to the protein content.
CELLULAR LABILE IRON POOL (LIP) EVALUATION
The cellular labile iron content was estimated by a ﬂuorimetric assay
using the metalsensitive probe calcein (CA) and the iron chelator SIH
(salicylaldehyde isonicotinoyl hydrazone), generously provided
by Prof. Prem Ponka (McGill University, Montreal, QC, Canada),
as previously reported [Breuer et al., 1995; Maffettone et al., 2008;
Santamaria et al., 2011]. After incubation for 24 and 48 h with
cysteine 10mM, HaCaT cells, plated at a density of 1 104 cells/well,
were loaded with 0.5mM CA-AM (calcein-acetomethoxy, Molecular
Probes, Invitrogen, Eugene, OR) for 30min at 37°C in calcium- and
bicarbonate-free modiﬁed Krebs Henseleit buffer (KHB), consisting
of 20mM HEPES, pH 7.4, 119mM NaCl, 4.9mM KCl, 0.96mM
KH2PO4, and 5mM glucose. CA-AM rapidly penetrates across the
plasma membrane and is intracellularly hydrolysed to release free
CA. After loading, the cultures were washed two times with KHB.
Cellular CA ﬂuorescence was recorded in a Perkin Elmer microplate
reader (Perkin Elmer LS55 Luminescence Spectrometer) using a ﬁlter
combination with an excitation wavelength of 485 nm and an
emission wavelength of 530 nm (slits 5 nm). Cell cultures without
CA-AMwere used as blank to correct non-speciﬁc autoﬂuorescence.
Trypan blue was added in all experiments to eliminate extra-cellular
ﬂuorescence. Once hydrolyzed, calcein becomes trapped in the
cytoplasm and emits intense green ﬂuorescence. The calcein-loaded
cells have a ﬂuorescence component (DF) that is quenched by
intracellular iron and can be revealed by addition of 100mM SIH.
The rise in ﬂuorescence is equivalent to the change in calcein
concentration or to the amount of cellular iron originally bound to
CA. Thus, the changes in CA ﬂuorescence intensity were directly
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proportional to the iron labile pool. To characterize the responsive-
ness of CA ﬂuorescence toward different concentrations of intra-
cellular iron, cells were preloaded for 18 h with ferrous ammonium
sulphate (FAS), ferric ammonium citrate (FAC) or with the ferrous
iron chelator desferrioxamine (DFO).
STATISTICAL ANALYSIS
All the experiments have been repeated four times. Data were
presented as mean SEM and the statistical analysis was performed
using Graph-Pad Prism (Graph-Pad software Inc., San Diego, CA),
and ANOVA test for multiple comparisons followed by Bonferroni0s
test.
RESULTS
CYSTEINE IN VITRO BIOSCREEN
Preliminary biochemical and toxicological investigations were
performed to screen the cysteine bioactivity in vitro. In particular,
we ﬁrst focused on the evaluation of cell growth and viability
following the administration of various concentrations of cysteine
(the range 103!102mMhas been explored) on human keratinocytes
(HaCaT cell line). Data concerning the antiproliferative cisplatin
(cDDP)—a positive control for cytotoxic effects—are included.
Bioscreens were performed up to 72h of incubations and have
allowed to determine the range of concentration and incubation times
to carry out in vitro treatments under optimal conditions of cell
growth and protein biosynthesis. The experimental procedure has
involved the evaluation of the cellular metabolic activity by the MTT
assay, and the estimation of the live/dead cells ratio by a speciﬁc
ﬂuorimetric assay. The results are presented in Figure 1 and taken
together show that cysteine, for all the screened concentrations and
times, does not interfere with the HaCaT keratinocytes viability.
Indeed, even at the higher cysteine concentration (100mM), no
signiﬁcant changes in cellmetabolic activity (Fig. 1A), aswell as in the
live/dead cell ratio (Fig. 1B), were detected with respect to control
cultures. Similarly and to support, following in vitro exposure to high
concentration of cysteine no morphological modiﬁcation of HaCaT
subconﬂuent monolayers appeared when examined by phase-
contrast lightmicroscopy for the dynamic cell populationmonitoring
(data not shown). Therefore, these outcomes would suggest the
theoretical safety of cysteine administration to human keratinocytes,
thus allowing us to use it in a wide range of concentrations.
CYSTEINE TREATMENT RESULTS IN AN INCREASED BIOSYNTHESIS
OF KERATINS IN HaCaT CELLS
To determine whether cysteine supplementation regulates keratin
expression, HaCaT cells were incubated in a growth medium
containing a range of cysteine concentrations (1, 10, and 100mM)
for 24, 48, and 72 h. After incubations, the levels of keratins in the
Fig. 1. Cysteine in vitro bioactivity. (A) Cell viability was evaluated by the MTT assay. HaCaT cells were treated for the indicated times (24, 48, and 72 h) with a range of
concentrations of cysteine (103 ! 102mM). Results are expressed in table as the percentage of cell viability to untreated control cultures and are reported as mean SEM
(n¼ 5) of four independent experiments. Cisplatin is the positive control for cytotoxicity (cDDP, cis-diamminedichloroplatinum). (B) Inversely correlated ﬂuorescent measures
for live and dead cells counting after cysteine treatments. HaCaT cells were incubated with cysteine for the indicated times and concentrations, and then the MultiTox-Fluor
Multiplex Cytotoxicity Assay (Promega) was performed according to themanufacturer0s instructions. Results are reported in line graphs as mean percentage SEM (n¼ 5) of live
and dead cells of four independent experiments.
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soluble and insoluble fractions were evaluated by Western blot
analysis using a broad spectrum anti-Pan keratin antibodies, as
described in the experimental section. In vitro treatments with
cysteine resulted in a signiﬁcant increase of keratin expressionwithin
both the soluble and insoluble fraction. As reported in Figure 2, the
cellular content of cytokeratins in the soluble fraction was clearly
enhanced at the all examined times, reaching themaximum following
48h of cysteine exposure. In the same experimental conditions, an
equalmarked increase in the keratins insoluble fractionwas observed,
with the more evident effects after 48 and 72h (Fig. 3). Notably, some
cytokeratin isoforms—i.e., K5, K6/K10, K18, and K19—reached an
expression level close to 400% with respect to control cultures
(Fig. 3B). It is noteworthy that keratin cellular content remained
high even after 72 h of treatment, albeit at lower levels with respect to
48h—an effect probably due to protein turnover.
By assuming that cysteine enhances the keratins cellular content,
we next assessed de novo protein synthesis to further investigate
cysteine role in the regulation of keratins expression. For that reason,
following HaCaT exposure to 10mM cysteine for 48 h we measured
by immunoprecipitation the [35S]-methionine incorporation into
cytokeratins. The results are depicted in Fig. 4 and provide clearly
evidence that the incorporation rate of 35S-methionine into keratins
increased after cysteine supplementation. As shown by densito-
metric analysis (Fig. 4C and 4D), 35S-labelling was more pronounced
for the keratin insoluble fraction, particularly for K1, K4, K5, K6/K10,
K18 keratin isoforms. Consequently, we can state that in human
keratinocytes cysteine is able to induce an increase of keratins
biosynthesis at a relatively low concentration (10mM), albeit by
different protein translation rates.
CYSTEINE TREATMENT PREVENTS THE REDUCTION OF KERATIN
EXPRESSION CAUSED BY IRON DEFICIENCY
Next, we investigated the interplay of cysteine supplementation and
cellular iron status in regulating the cytokeratin expression. To
modify the intracellular iron level, HaCaT cells were pre-treated
with ferric ammonium citrate (FAC), as a source of iron, or with
Fig. 2. Cysteine effect on keratins expression in soluble fraction of HaCaT cells. (A)Western blot analysis showing the keratin levels in soluble fraction of HaCaT cells exposed to
cysteine (1, 10, and 100mM) for 24, 48, and 72 h. Equal amounts of proteins (50mg) were separated on a 10% SDS–polyacrylamide gel and subjected to Western blot analysis
using monoclonal anti-Pan cytokeratin antibodies that recognize the following human cytokeratins according to their molecular weight: K1 (68 kDa), K4 (59 kDa), K5 (58 kDa),
K6/K10 (56 kDa), K13 (54 kDa), K8 (52 kDa), K18 (45 kDa), and K19 (40 kDa). Molecular weight marker position (MW) is reported. Shown are blots representative of four
independent experiments. (B) After chemoluminescence, the corresponding bands were quantiﬁed by densitometric analysis and plotted in line graphs as percentage of control.
The anti-b-actin antibody was used to standardize the amounts of proteins in each lane. Shown are the averages SEM values of four independent experiments.
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desferrioxamine (DFO), an iron chelator, for 18 h via standardized
protocols to avoid generating iron-dependent oxidative stress or
impairment of cell viability, respectively. Firstly, Western blot
analysis in Figure 5A and 5C demonstrates that in vitro iron overload
by FAC treatment induced a signiﬁcant increase in cellular keratin
content with respect to control cells. Conversely, iron deﬁciency
by DFO signiﬁcantly decreased keratins levels. As clearly depicted
in the related bar graphs (Fig. 5B and 5D), these effects were
evident for both the soluble and the insoluble keratin fractions and
could result plausibly by an imbalance of cellular iron homeo-
stasis. Indeed, the estimation by the calcein ﬂuorimetric assay
has shown important perturbations in intracellular LIP amounts
following iron repletion/depletion (see Fig. 6C). Notably, the
concurrent cysteine supplementation (10 and 100mM for 48 h) was
able to signiﬁcantly counteract, in a concentration-dependent
manner, the reduction in keratins synthesis induced by iron
depletion, mainly at the lower cysteine concentration (10mM) in
the insoluble fraction. Moreover, cysteine did further increase the
keratin expression induced by iron repletion, albeit in a non-fully
additive manner.
EFFECT OF CYSTEINE ON CELLULAR IRON HOMEOSTASIS
To explore the molecular mechanisms by which cysteine counteracts
the negative effect of iron deﬁciency on keratin biosynthesis, we
examined the cellular content of the main proteins involved in
iron metabolism, such as ferritin, TfR-1, IRP1, and IRP2, following
in vitro cysteine supplementation. Toward this aim, HaCaT cells
were exposed to 10mM cysteine for 24 and 48 h and the expression
of ferritin, TfR-1, IRP1, and IRP2 was evaluated by Western
blot analysis. As shown in Figure 6A and 6B, cysteine treatment
induced a signiﬁcant increase of the iron related-protein expression,
which wasmore evident after 24 h of treatment. In particular, ferritin
content increased of about 1.6 and 1.4-fold, whereas TfR-1 levels
increased of about 1.8 and 1.2-fold after 24 h and 48 h of cysteine
treatment with respect to control cultures. With regard to Iron
Regulatory Proteins, the bifunctional c-Aconitase/IRP1 showed
Fig. 3. Cysteine effect on keratins levels in insoluble fraction of HaCaT cells. (A) Western blot analysis showing the keratin levels in insoluble fraction of HaCaT cells exposed to
cysteine (1, 10, and 100mM) for 24, 48, and 72 h. Equal amounts of proteins (50mg) were separated on a 10% SDS–polyacrylamide gel and subjected to Western blot analysis
using anti-Pan mixture, as indicated in the legend of Figure 2. Molecular weight marker position (MW) is reported. Shown are blots representative of four independent
experiments. (B) After chemoluminescence, the bands detectable in control lines (K4, K5, K6/10, K18, K19) were quantiﬁed by densitometric analysis and plotted in line graphs as
percentage of control. The anti-b-actin antibody was used to standardize the amounts of proteins in each lane. Shown are the averages SEM values of four independent
experiments.
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a slight but signiﬁcant increase following 24 h of cysteine treatment
as compared to untreated cells, whereas IRP2—expressed at
very low levels—resulted substantially unaffected by cysteine
supplementation.
Finally, to verify whether the effects of cysteine on the expression
of the proteins involved in ironmetabolismmay lead to variations in
the free cellular iron content, we measured LIP amount using the
calcein ﬂuorimetric assay. The results obtained in HaCaT cells
treated for 24 and 48 h with 10mM cysteine are represented in line
graph (Fig. 6C) and demonstrate that LIP extent remained essentially
unaltered compared to control cells. On the other hand, variations in
LIPmagnitude were triggered by iron repletion/depletion, using FAC
and DFO, respectively. Overall, the effect of cysteine supplementa-
tion on the cytosolic chelatable iron pool is correlated with the
concomitant up-regulation of TfR-1 and ferritin detected in human
keratinocytes.
Interestingly, cysteine treatment did not change signiﬁcantly the
LIP extent in iron-repleted cells, while it was able to partially restore
the cellular metal homeostasis in iron-depleted cells, giving rise in
the latter case to a LIP extent similar to that of untreated cells. This
effect is likely due to the cysteine-mediated induction of ferritin but
especially of TfR-1 at the cell membrane.
DISCUSSION
By virtue of its ability to form disulﬁde bonds, cysteine plays a
crucial role in protein structure and in protein-folding pathways, so
that it is currently recognized as a conditionally essential amino
acid. Moreover, it is crucial in metabolic pathways involving
methionine, taurine and glutathione [Brosnan and Brosnan, 2006];
as a rate-limiting substrate for GSH production, by triggering
Fig. 4. Cysteine promotes keratin synthesis in HaCaT cells. (A, B) Cells were labeled with L-[35S]-methionine during the last 3 h of cysteine in vitro exposure (10mM for 48 h).
Aliquots from soluble (A) and insoluble (B) fractions were immunoprecipitated with anti-Pan cytokeratin antibodies and proteins were then subjected to 10%SDS–PAGE analysis
and autoradiography. Molecular weight marker position (MW) is reported. The autoradiograms shown are representative of four independent experiments. (C, D) The bands
corresponding to cytokeratins 1, 4, 5, 6/10, and 18 from soluble (C) and insoluble (D) fractions were quantiﬁed by densitometric analysis and plotted in bar graphs as mean
percentage of untreated control cultures SEM of four independent experiments.  P< 0.001 vs. control cells.
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antioxidant defences, cysteine is also engaged in several stressed and
inﬂammatory states [McPherson and Hardy, 2011].
Among the cysteine-rich proteins, keratins are fundamental in
epidermal development and homeostasis, in which cysteine is
required for the disulﬁde bridges that confer additional strength and
rigidity by permanent thermally stable cross-linking. Accordingly,
over recent years the use of dietary cysteine and/or its derivatives
as functional food supplements has greatly increased. In this
context, we have herein demonstrated that cysteine supplementation
promotes a signiﬁcant up-regulation of keratins expression in
human keratinocytes. The resulting de novo protein synthesis
involved keratins accumulation within cells, thereby determining a
remarkable increase in their cellular content.
The increase of keratin synthesis by cysteine is conceivable taking
into account that this amino acid is an important substrate for
protein translation. Indeed, as is the case of some amino acids
(leucine, isoleucine, and valine) in human skeletal muscle, cysteine
has anabolic effects on protein metabolism by increasing protein
synthesis and decreasing protein degradation [Blomstrand et al.,
2006]. For example, an exogenous supply of cysteine was needed
to maintain maximal rates of protein synthesis in the perfused rat
heart, suggesting an effect of cysteine on protein synthesis [Chua
et al., 1984]. It is well known that amino acids regulate metabolic
pathways involved in protein synthesis, such as mammalian target
of rapamycin (mTOR), ribosomal S6 kinase (p70S6K), eukaryotic
initiation factor 2B (eIF2), and eukaryotic initiation factor 4E binding
protein (4E-BP1) [Meijer and Dubbelhuis, 2004; Prod0homme et al.,
2004; Proud, 2004]. Indeed, a stimulatory effect of oral administration
of amino acids, particularly leucine, onmTOR, p70 S6 kinase, and the
eukaryotic initiation factors has been demonstrated in vivo [Kimball
and Jefferson, 2004]. Moreover, many of the cysteine biological
effects at cellular level are closely associated to its role in promoting
glutathione (g-glutamyl-cysteinyl-glycine, GSH) synthesis, themajor
intracellular antioxidant. As a key functional component of GSH,
cysteine provides a reactive thiol group that binds directly to different
types of free radicals, including reactive oxygen and nitrogen species
(ROS and RNS, respectively), thereby playing a variety of roles in
detoxiﬁcation, redox regulation and cellular signaling [Lushchak,
Fig. 5. Cysteine supplementation and cellular iron status in regulating the cytokeratin expression. (A, C) Western blot analysis showing the keratin levels in soluble (A) and
insoluble (C) fraction from iron depleted (DFO) or iron repleted (FAC) HaCaT cells exposed or not to cysteine (10 and 100mM) for 48 h, as indicated in the ﬁgure. Equal amounts
of proteins (50mg) were separated on a 10% SDS–polyacrylamide gel and subjected toWestern blot analysis using the anti-Pan cytokeratin antibodies. Molecular weight marker
position (MW) is reported. Shown are blots representative of four independent experiments. The anti-b-actin antibody was used to standardize the amounts of proteins in each
lane. (B, D) Total cytokeratins cellular content emerging from each Western blot lane of soluble (B) and insoluble (D) fractions, quantiﬁed by densitometric analysis and plotted
in bar graphs as mean percentage of untreated control cultures SEM of four independent experiments.  P< 0.001 vs. control cells; °°° P< 0.001 vs. iron depleted cells
(DFO); ### P< 0.001 vs. iron repleted cells (FAC).
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2012]. Several biological processes regulated throughGSH are critical
to proliferating cell systems—like epithelia—and include cell growth,
differentiation and apoptosis. GSH also operates as cofactor for
antioxidant enzymes, such as glutathione peroxidases, glutathione
transhydrogenases and glutathione transferases. In accordance,
several studies have demonstrated that cysteine supplementation is
able to preserve healthy state of skin and hair, reducing the symptoms
of androgenic alopecia, and protecting hair follicles against oxidative
stress [Tr€ueb, 2009; Wagener et al., 2013].
By analyzing in the interplay of cysteine supplementation and
cellular iron status in the regulation of cytokeratin expression, we
found that the simultaneous exogenous supplementation of both
cysteine and iron results in a further increase of keratins levels. As
well as cysteine, intracellular iron seems to be another key factor
in regulating keratins expression in epidermal tissues [Hirobe,
2009]. Indeed, we have shown that a cellular iron deﬁciency status
by desferrioxamine-mediated metal chelation negatively affects
keratins expression. This effect can be explained according to the
special role played by iron, particularly in cells endowed with a
very high proliferative activity, as an essential component of
fundamental biochemical activities. One of the most surprising
ﬁndings emerging from our study is that cysteine supplementa-
tion seems able to revert the adverse effect of iron deﬁciency on
cellular keratin expression. One of the reasons may lie in the
regulatory role of this amino acid on protein biosynthesis and
turnover. As reported for keratins, cysteine availability leads to
a synthesis induction of many other proteins, including those
involved in iron metabolism. Indeed our results have shown a
signiﬁcant cysteine-induced up-regulation of TfR-1, ferritin and
IRP1, among the most important cellular proteins required for the
maintenance of iron homeostasis. This induction is particularly
detectable after 24 h of cysteine treatment, and mainly concerns
the TfR-1, required for iron intake into the cell. The TfR-1 over-
expression at the cell membrane allows metal entry, thereby
restoring iron content. The concomitant increase in ferritin
protein—the major regulator of the cellular iron content—may
allow safe storage of any excess iron, thus limiting the potential
oxidative stress induction by free iron within cells. In fact, by
acting as a buffer against iron deﬁciency and iron overload,
ferritin provides protection against oxidative stress. This result is
consistent with the estimation of the cellular free iron content,
showing no substantial changes in labile iron pool (LIP) following
cysteine supplementation, and a trend toward a recovery of LIP
when cysteine was administered in iron depleted cells. LIP is
fundamental in preserving cellular biochemical activities since it
represents the catalytic and redox-active iron; its level must be
maintained within a limited range that assures the iron supplies
for the cell and prevents iron excess causing oxidative damage
[Kakhlon and Cabantchik, 2002]. Consequently, as evidenced by
the recovery of the keratin levels in iron depleted cells, the
restoration of iron homeostasis following treatment with cysteine
should occur without creating cellular dangerous pro-oxidant
conditions. This is an important endpoint. Actually, these ﬁndings
further reinforce the idea of a regulatory role in protein synthesis
for cysteine, in conjunction with its antioxidant protective
functions.
Fig. 6. Cysteine effect on iron homeostasis in keratinocytes. (A) Western blot
analysis showing ferritin, TfR-1, IRP1 and IRP2 levels in HaCaT cells incubated
with 10mM cysteine for 24 and 48 h, as described in the experimental section.
(B) Densitometric analysis of the bands corresponding to ferritin, TfR-1, IRP1,
and IRP2, reported in line graphs as percentage of control. The anti-b-actin
antibody was used to standardize the amounts of proteins in each lane. Shown
are the averages SEM values of four independent experiments.  P< 0.001
vs. control cells;  P< 0.01 vs control cells;  P< 0.05 vs. control cells. (C) LIP
extent variations estimated by the CA ﬂuorescent method in iron depleted
(DFO) or iron repleted (FAC) HaCaT cells incubated or not with 10mM cysteine
for 24 and 48 h. Additional control cultures were exposed only to 10mM
cysteine for 24 and 48 h. Shown are the average SEM (n¼ 5) values of three
independent experiments plotted in a line graph as percent of control untreated
cultures.  P< 0.001 vs. control cells; °°° P< 0.001 vs. iron depleted cells
(DFO); °° P< 0.01 vs. iron depleted cells (DFO).
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In addition, but not less relevant for rapid proliferating epidermal
cells, the enhanced iron metabolic availability induced by cysteine
should make possible its incorporation into the ribonucleotide
reductase, where it plays a crucial role in the reduction of
ribonucleotides to deoxyribonucleotides for DNA biosynthesis,
thus allowing cell proliferation [Cooper et al., 1996]. Furthermore,
a recent study has demonstrated that DNA polymerases activity is
strictly dependent by an iron–sulphur cluster, which plays an
essential role in their biological function and whose assembly
directly depends on cellular iron availability [Netz et al., 2011].
In conclusion, the herein presented study provides convincing
evidence of the interplay between cysteine and cellular iron
homeostasis. Cysteine and iron cooperate in human keratinocytes
for keratins expression, suggesting their central role in maintaining
healthy epithelia. Via induction of iron-related proteins, the
enhanced metabolic iron availability by cysteine supplementation
reﬂects this relationship and suggests that cysteine can balance the
trophic and toxic properties of iron.
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